36 results
Page 2 of 2
8-K
EX-99.2
7e966 ouk8eg
7 Nov 22
Day One Reports Third Quarter 2022 Financial Results and Corporate Progress
4:31pm
8-K
EX-99.2
yuwmd51mi 402nc
12 Sep 22
Day One Appoints Garry Nicholson as Chairman of the Board of Directors
8:40am
8-K
EX-99.2
ppbvxyc283xx6b
4 Aug 22
Day One Reports Second Quarter 2022 Financial Results and Corporate Progress
4:53pm
8-K
EX-99.1
ofi7zt 3lhlv2sjmg2
24 Jun 22
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
EX-99.2
v4amens
13 Jun 22
Day One Announces Positive Initial Data from Pivotal FIREFLY-1 Trial of Tovorafenib (DAY101) in Relapsed Pediatric Low-Grade Glioma
6:24am
8-K
EX-99.2
m73u68die6i
12 May 22
Day One Reports First Quarter 2022 Financial Results and Provides Business Update
4:33pm
8-K
EX-99.1
hc7yko n7
13 Apr 22
Targeted Therapies for People of All Ages April 2022
8:01am
10-K
lacwfxvo3s oeyoek
7 Mar 22
Annual report
7:36am
8-K
EX-99.2
glos svo7z84rqps
7 Mar 22
Day One Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Progress
7:30am
8-K
EX-99.2
eyn9x
5 Jan 22
Day One to Present at the 40th Annual J.P. Morgan Healthcare Conference
8:01am
8-K
EX-99.2
0io1xjs695d5n
10 Aug 21
Day One Reports Second Quarter 2021 Financial Results and Corporate Progress
4:15pm
424B4
khduz 2gwq7n
27 May 21
Prospectus supplement with pricing info
4:18pm
S-1/A
351 dmyno8cuk7y2
24 May 21
IPO registration (amended)
6:16am
S-1
g0na9l
4 May 21
IPO registration
4:12pm
DRS
k5dkywz36ma
19 Mar 21
Draft registration statement
12:00am